BIOMAT Database Logo BIOMAT Database Logo

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. 1995

J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Department of Pathology, University and National Hospital of Iceland, Reykjavik.

We examined DNA from 116 female and four male breast cancer patients for loss of heterozygosity (LOH). DNA was analysed by polymerase chain reaction using ten microsatellite markers on chromosome 11. Three distinct regions of LOH were identified: 11p15.5, 11q13 and 11q22-qter with a LOH frequency of 19, 23 and 37-43% respectively. The marker D11S969 showing the highest frequency of LOH (43%) is located at the 11q24.1-q25 region. No previous molecular genetic studies have shown frequent LOH at the region telomeric to q23 on chromosome 11. Southern analysis revealed that LOH at 11q13 was due to amplification, whereas LOH at 11q22qter was due to deletion. LOH at 11p15.5 was associated with paucity of hormone receptor proteins, high S-phase and positive node status. An association was found between LOH at 11q13 and positive node status. LOH at the 11q22-qter region correlated with a high S-phase fraction. A significant association was found between LOH at 11p15 and chromosome regions 17q21 (the BRCA1 region) and 3p.

UI MeSH Term Description Entries
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D004276 DNA, Satellite Highly repetitive DNA sequences found in HETEROCHROMATIN, mainly near centromeres. They are composed of simple sequences (very short) (see MINISATELLITE REPEATS) repeated in tandem many times to form large blocks of sequence. Additionally, following the accumulation of mutations, these blocks of repeats have been repeated in tandem themselves. The degree of repetition is on the order of 1000 to 10 million at each locus. Loci are few, usually one or two per chromosome. They were called satellites since in density gradients, they often sediment as distinct, satellite bands separate from the bulk of genomic DNA owing to a distinct BASE COMPOSITION. Satellite DNA,Satellite I DNA,DNA, Satellite I,DNAs, Satellite,DNAs, Satellite I,I DNA, Satellite,I DNAs, Satellite,Satellite DNAs,Satellite I DNAs
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome

Related Publications

J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity on chromosome 11 q in breast cancer.
May 1995, Journal of clinical pathology,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity at chromosome 1p in human breast cancer.
October 1996, International journal of oncology,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
March 1995, British journal of cancer,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity, chromosome 7q, and breast cancer.
June 1992, Lancet (London, England),
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity on chromosome 7q31 in breast cancer.
May 1993, Lancet (London, England),
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
[Cancer of the breast. Genetic alterations and prognostic factors].
September 1990, Pathologie-biologie,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
[Prognostic significance of loss of heterozygosity in breast cancer].
April 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer.
April 2000, Cancer letters,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
January 2002, Breast cancer research : BCR,
J Gudmundsson, and R B Barkardottir, and G Eiriksdottir, and T Baldursson, and A Arason, and V Egilsson, and S Ingvarsson
Loss of heterozygosity on chromosome 1q in human breast cancer.
September 1989, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!